BRAF and colonic neoplasm: In a previous study that compared the tumor immune microenvironment of BRAF mutant (BrafV600ELgr5CreMin; BLM) and BRAF wildtype (Min) mouse colon tumors, CIBERSORT analysis of RNA-sequencing data revealed an enrichment for MCs in BRAF mutant tumors [6].